Exhibit 99.1
AXCELIS ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER 2013
BEVERLY, Mass. — May 2, 2013—Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the quarter ended March 31, 2013. The Company reported first quarter revenue of $40.7 million, compared to $44.6 million for the fourth quarter of 2012. Net loss for the quarter was $9.0 million, or $(0.08) per share, which includes: a $0.4 million milestone payment from the dry strip asset sale to Lam Research Corporation; a $2.1 million charge associated with an inventory write off of 300mm dry strip production components; and $1.8 million of restructuring charges. This compares to a net loss for the fourth quarter of 2012 of $14.8 million, or ($0.14) per share, which included: a $7.9 million gain from the dry strip asset sale to Lam Research; a $13.4 million charge associated with an inventory write off; and $0.6 million of restructuring charges. Cash and cash equivalents were $42.4 million at March 31, 2013 compared with $45.0 million at December 31, 2012.
Chairman and CEO Mary Puma said, “During the quarter our Purion M medium current ion implanter was selected for evaluation by two new customers, representing both memory and foundry market segments. Earlier this week we announced the introduction of the Purion XE, a high energy ion implanter, the second member of our Purion platform family. Our Purion platform is the foundation for all future generation Axcelis implanters. Purion products are key to our future success and will allow us to quickly capitalize on improving market conditions.”
Ms. Puma added, “Each member of the Purion family shares a common, powerful 500+ wafers per hour single wafer end station, industry leading source technology and an innovative and productive ultra-pure beam line. The Purion platform was developed in response to customer requirements for absolute beam purity and the most precise dopant placement possible, while ensuring the highest levels of productivity and capital efficiency. The Purion platform redefines next generation implanter technology and performance and enables the efficient production of leading edge semiconductor devices.”
First Quarter 2013 Conference Call
The Company will host a conference call today at 5:00 pm ET to discuss results for the first quarter of 2013. An audio webcast will be available on the Investor page of Axcelis’ website at www.axcelis.com, or by dialing 1.888.680.0878 (1.617.213.4855 outside North America). Participants calling into the conference call will be requested to provide the passcode: 43640965. A replay of the webcast will be available for 30 days following the conference call.
Safe Harbor Statement
The conference call will contain forward-looking statements under the SEC safe harbor provisions. These statements, which include our guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties, many of which are outside the control of the Company, including the timing of orders and shipments, the conversion of orders to revenue in any particular quarter, or at all, the continuing demand for semiconductor equipment, relative market growth, continuity of business relationships with and purchases by major customers, competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and global economic, political and financial conditions. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.
About Axcelis
Axcelis Technologies, Inc. (Nasdaq: ACLS) headquartered in Beverly, Massachusetts, has been providing innovative, high-productivity solutions for the semiconductor industry for over 35 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation, one of the most critical and enabling steps in the IC manufacturing process. The Company’s Internet address is: www.axcelis.com.
Company Contacts
Financial Community:
Jay Zager
978.787.9408
Editorial/Media Community:
Maureen Hart
978.787.4266
Axcelis Technologies, Inc.
Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)
|
| Three months ended |
| ||||
|
| 2013 |
| 2012 |
| ||
Revenue |
|
|
|
|
| ||
Product |
| $ | 34,452 |
| $ | 47,538 |
|
Services |
| 6,274 |
| 7,468 |
| ||
Total revenue |
| 40,726 |
| 55,006 |
| ||
Cost of revenue |
|
|
|
|
| ||
Product |
| 22,181 |
| 29,284 |
| ||
Services |
| 5,602 |
| 5,186 |
| ||
Total cost of revenue |
| 27,783 |
| 34,470 |
| ||
|
|
|
|
|
| ||
Gross profit |
| 12,943 |
| 20,536 |
| ||
|
|
|
|
|
| ||
Operating expenses |
|
|
|
|
| ||
Research and development |
| 9,206 |
| 11,669 |
| ||
Sales and marketing |
| 5,201 |
| 6,583 |
| ||
General and administrative |
| 6,590 |
| 7,799 |
| ||
Gain on sale of dry strip assets and intellectual property |
| (368 | ) | — |
| ||
Restructuring charges |
| 1,801 |
| 2,881 |
| ||
Total operating expenses |
| 22,430 |
| 28,932 |
| ||
|
|
|
|
|
| ||
Loss from operations |
| (9,487 | ) | (8,396 | ) | ||
|
|
|
|
|
| ||
Other income (expense) |
|
|
|
|
| ||
Interest income |
| 3 |
| 9 |
| ||
Other, net |
| 829 |
| (924 | ) | ||
Total other income (expense) |
| 832 |
| (915 | ) | ||
|
|
|
|
|
| ||
Loss before income taxes |
| (8,655 | ) | (9,311 | ) | ||
|
|
|
|
|
| ||
Income taxes |
| 333 |
| 717 |
| ||
|
|
|
|
|
| ||
Net loss |
| $ | (8,988 | ) | $ | (10,028 | ) |
|
|
|
|
|
| ||
Net loss per share |
|
|
|
|
| ||
Basic and Diluted |
| $ | (0.08 | ) | $ | (0.09 | ) |
|
|
|
|
|
| ||
Shares used in computing net loss per share |
|
|
|
|
| ||
Basic and diluted weighted average common shares |
| 108,227 |
| 107,067 |
|
Axcelis Technologies, Inc.
Consolidated Balance Sheets
(In thousands)
(Unaudited)
|
| March 31, |
| December 31, |
| ||
ASSETS |
|
|
|
|
| ||
Current assets |
|
|
|
|
| ||
Cash and cash equivalents |
| $ | 42,441 |
| $ | 44,986 |
|
Accounts receivable, net |
| 23,150 |
| 24,843 |
| ||
Inventories, net |
| 98,729 |
| 100,234 |
| ||
Restricted cash |
| 103 |
| 106 |
| ||
Prepaid expenses and other current assets |
| 5,519 |
| 5,056 |
| ||
Total current assets |
| 169,942 |
| 175,225 |
| ||
|
|
|
|
|
| ||
Property, plant and equipment, net |
| 33,663 |
| 34,413 |
| ||
Other assets |
| 12,352 |
| 12,520 |
| ||
Total assets |
| $ | 215,957 |
| $ | 222,158 |
|
|
|
|
|
|
| ||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
| ||
Current liabilities |
|
|
|
|
| ||
Accounts payable |
| $ | 13,793 |
| $ | 10,166 |
|
Accrued compensation |
| 8,900 |
| 7,283 |
| ||
Warranty |
| 1,539 |
| 1,700 |
| ||
Income taxes |
| 356 |
| 278 |
| ||
Deferred revenue |
| 5,714 |
| 6,423 |
| ||
Other current liabilities |
| 3,768 |
| 3,932 |
| ||
Total current liabilities |
| 34,070 |
| 29,782 |
| ||
|
|
|
|
|
| ||
Long-term deferred revenue |
| 321 |
| 456 |
| ||
Other long-term liabilities |
| 5,713 |
| 5,844 |
| ||
Total liabilities |
| 40,104 |
| 36,082 |
| ||
|
|
|
|
|
| ||
Stockholders’ equity |
|
|
|
|
| ||
Preferred stock, $0.001 par value, 30,000 shares authorized; none issued or outstanding |
| — |
| — |
| ||
Common stock, $0.001 par value, 300,000 shares authorized; 108,405 shares issued and 108,285 shares outstanding at March 31, 2013;108,293 shares issued and 108,173 shares outstanding at December 31, 2012 |
| 108 |
| 108 |
| ||
Additional paid-in capital |
| 505,478 |
| 504,643 |
| ||
Treasury stock, at cost, 120 shares at March 31, 2013 and December 31, 2012 |
| (1,218 | ) | (1,218 | ) | ||
Accumulated deficit |
| (331,465 | ) | (322,477 | ) | ||
Accumulated other comprehensive income |
| 2,950 |
| 5,020 |
| ||
Total stockholders’ equity |
| 175,853 |
| 186,076 |
| ||
Total liabilities and stockholders’ equity |
| $ | 215,957 |
| $ | 222,158 |
|
Axcelis Technologies, Inc.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
|
| Three months ended |
| ||||
|
| March 31, |
| ||||
|
| 2013 |
| 2012 |
| ||
Cash flows from operating activities |
|
|
|
|
| ||
Net loss |
| $ | (8,988 | ) | $ | (10,028 | ) |
Adjustments to reconcile net loss to net cash used for operating activities: |
|
|
|
|
| ||
Depreciation and amortization |
| 1,394 |
| 1,896 |
| ||
Gain on sale of dry strip assets and intellectual property |
| (368 | ) | — |
| ||
Deferred taxes |
| 56 |
| 378 |
| ||
Stock-based compensation expense |
| 839 |
| 1,082 |
| ||
Provision for excess inventory |
| 2,211 |
| 248 |
| ||
Changes in operating assets & liabilities |
|
|
|
|
| ||
Accounts receivable |
| 1,458 |
| 4,810 |
| ||
Inventories |
| (1,672 | ) | (8,277 | ) | ||
Prepaid expenses and other current assets |
| (544 | ) | (385 | ) | ||
Accounts payable and other current liabilities |
| 5,043 |
| (2,162 | ) | ||
Deferred revenue |
| (843 | ) | (3,818 | ) | ||
Income taxes |
| 84 |
| 76 |
| ||
Other assets and liabilities |
| (549 | ) | 6,483 |
| ||
Net cash used for operating activities |
| (1,879 | ) | (9,697 | ) | ||
|
|
|
|
|
| ||
Cash flows from investing activities |
|
|
|
|
| ||
Proceeds from sale of dry strip assets and intellectual property |
| 400 |
| — |
| ||
Expenditures for property, plant, and equipment |
| (150 | ) | (141 | ) | ||
(Increase) decrease in restricted cash |
| 3 |
| (3 | ) | ||
Net cash provided by (used for) investing activities |
| 253 |
| (144 | ) | ||
|
|
|
|
|
| ||
Cash flows from financing activities |
|
|
|
|
| ||
Proceeds from exercise of stock options |
| 49 |
| 802 |
| ||
Proceeds from Employee Stock Purchase Plan |
| — |
| 175 |
| ||
Net cash provided by financing activities |
| 49 |
| 977 |
| ||
Effect of exchange rate changes on cash |
| (968 | ) | (795 | ) | ||
Net decrease in cash and cash equivalents |
| (2,545 | ) | (9,659 | ) | ||
Cash and cash equivalents at beginning of period |
| 44,986 |
| 46,877 |
| ||
Cash and cash equivalents at end of period |
| $ | 42,441 |
| $ | 37,218 |
|